HIGHLIGHTS
- who: Hannah Kipka and colleagues from the ctoral Program Clinical Pharmacy, University Hospital, LMU Munich, Munich, Germany have published the paper: The Effects of the Levosimendan Metabolites OR-1855 and OR-1896 on Endothelial Pro-Inflammatory Responses, in the Journal: Biomedicines 2023, x of /2023/
- what: The authors thus investigated the impact of the metabolites OR-1896 and OR-1855 processes in vitro. The authors show that the levosimendan metabolites OR-1855 and OR-1896, in contrast to levosimendan, do not affect endothelial inflammatory adhesion molecule expression but cytokine-induced MAPK activation leading to cellular . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.